International Business Times |
Heron's (HRTX) Sustol For Chemotherapy-Induced Nausea Approved By FDA In Third Attempt
International Business Times The U.S. Food and Drug Administration finally approved Heron Therapeutics Inc.'s long-acting injection to prevent chemotherapy-induced nausea and vomiting that had previously been rejected two times. There will be about 1,685,210 new cases of cancer in ... FDA approves extended-release anti-nausea drug FDA approves Heron's therapy for chemotherapy-induced nausea FDA Approved Heron's Sustol To Prevent Chemotherapy Induced Nausea and Vomiting |
from Health - Google News http://news.google.com/news/url?sa=t&fd=R&ct2=us&usg=AFQjCNFyXSQ05yqsg0gLCJAyBvFBzLLjUA&clid=c3a7d30bb8a4878e06b80cf16b898331&cid=52779177912091&ei=ZIOsV9D0CILP3gGsgYrAAQ&url=http://www.ibtimes.com/herons-hrtx-sustol-chemotherapy-induced-nausea-approved-fda-third-attempt-2400162
via IFTTT
No comments:
Post a Comment